164 related articles for article (PubMed ID: 15598942)
1. A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)--the 4th study.
Nakagawa M; Tanaka F; Tsubota N; Ohta M; Takao M; Wada H;
Ann Oncol; 2005 Jan; 16(1):75-80. PubMed ID: 15598942
[TBL] [Abstract][Full Text] [Related]
2. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
[TBL] [Abstract][Full Text] [Related]
3. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
4. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Wada H; Miyahara R; Tanaka F; Hitomi S
Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
[TBL] [Abstract][Full Text] [Related]
5. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
Soh J; Toyooka S; Okumura N; Nakamura H; Nakata M; Yamashita M; Sakamoto J; Aoe M; Hotta K; Morita S; Date H
Int J Clin Oncol; 2019 Nov; 24(11):1367-1376. PubMed ID: 31312931
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Miyahara R; Wada H
Cancer Sci; 2004 Apr; 95(4):371-6. PubMed ID: 15072598
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Wada H; Hitomi S; Teramatsu T
J Clin Oncol; 1996 Apr; 14(4):1048-54. PubMed ID: 8648356
[TBL] [Abstract][Full Text] [Related]
9. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
Hamada C; Tsuboi M; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Thorac Oncol; 2009 Dec; 4(12):1511-6. PubMed ID: 19875974
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Kato H; Ichinose Y; Ohta M; Hata E; Tsubota N; Tada H; Watanabe Y; Wada H; Tsuboi M; Hamajima N; Ohta M;
N Engl J Med; 2004 Apr; 350(17):1713-21. PubMed ID: 15102997
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant chemotherapy for non-small cell lung cancer].
Otake Y; Tanaka F; Wada H; Hitomi S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1245-51. PubMed ID: 9279343
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery.
Endo C; Saito Y; Iwanami H; Tsushima T; Imai T; Kawamura M; Kondo T; Koike K; Handa M; Kanno R; Fujimura S;
Lung Cancer; 2003 May; 40(2):181-6. PubMed ID: 12711119
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
14. A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer.
Ueda H; Sakada T; Kuwahara M; Motohiro A
Anticancer Drugs; 2004 Jan; 15(1):29-33. PubMed ID: 15090740
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
Wada H; Tanaka F; Hitomi S
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):98-102. PubMed ID: 9348578
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer.
Tanaka F; Otake Y; Yanagihara K; Yamada T; Miyahara R; Kawano Y; Li M; Inui K; Wada H
Br J Cancer; 2001 Jan; 84(2):263-9. PubMed ID: 11161386
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC).
Saito J; Nakai Y; Saijo Y; Nukiwa T; Koinumaru S; Matsuura Y; Aso N; Yamane Y; Tsukamoto T; Sayama T; Nakabayashi T
Lung Cancer; 2001; 31(2-3):285-93. PubMed ID: 11165409
[TBL] [Abstract][Full Text] [Related]
18. Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
Nakagawa K; Tada H; Akashi A; Yasumitsu T; Iuchi K; Taki T; Kodama K;
Br J Cancer; 2006 Oct; 95(7):817-21. PubMed ID: 16969350
[TBL] [Abstract][Full Text] [Related]
19. UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study Group.
Ichinose Y; Yosimori K; Yoneda S; Kuba M; Kudoh S; Niitani H
Cancer; 2000 Jan; 88(2):318-23. PubMed ID: 10640963
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
Eur J Surg Oncol; 1995 Feb; 21(1):69-77. PubMed ID: 7851558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]